SI
SI
Advertise on SI

 Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?



To: dorightbythem who wrote (12173)10/22/2010 12:00:45 PM
From: dorightbythemRespond to of 21237
 
I agree with your assessment and look forward to seeing the results of the COG Trial. I hope the FDA shares your sentiment.



To: dorightbythem who wrote (12173)10/22/2010 12:16:17 PM
From: stockdoc77Read Replies (1) | Respond to of 21237
 
These are two new trials in adults. The first just opened this year and is scheduled to enroll through 2016. The second opened last year. The COG trial of pediatric relapsed ALL is different, that will hopefully wrap up in next few months and then report data mid 2011.


Copyright © 1995-2013 Knight Sac Media. All rights reserved.